Skip to main content
PMC home page
Clinical Cardiology logoLink to Clinical Cardiology
. 2009 Feb 3;20(Suppl 1):39–48. doi: 10.1002/clc.4960201309

Impact of contrast echocardiography on diagnostic algorithms: Pharmacoeconomic implications

Leslee J Shaw 1,2
PMCID: PMC6656058  PMID: 9383601

Abstract

The major goal of medicine in the era of managed care is to control escalating costs and to attain a high level of quality health care. Capitation has limited access to expensive and unnecessary testing, placing an emphasis on the prudent use of available technology. A vast armamentarium of available diagnostic screening tests are available within cardiology. Routine two‐dimensional (2‐D) echocardiography is a high‐quality, low‐cost test that provides enhanced portability and real‐time test interpretation over other noninvasive test modalities. The echocardiogram may cost up to 50% less than competitive nuclear single‐photon emission computed tomography (SPECT) imaging. However, on average 10% of routine and 33% of stress echocardiograms are suboptimal (disproportionately affecting obese patients and those with lung disease). Myocardial contrast echocardiography has been shown to provide enhanced endocardial border delineation and left ventricular opacification, to enhance Doppler signal, and to provide information on myocardial perfusion. In several recent phase II and III studies, the use of a contrast agent has been shown to improve the diagnostic accuracy of echocardiography substantially. Improvements in the diagnostic capabilities of echocardiography have been shown to (1) impact upon downstream repetitive testing in patients with an initially nondiagnostic echocardiogram, (2) potentially increase laboratory throughput, and (3) reduce the rate of false‐positive and negative tests as a result of improved image quality. As clinical and cost‐effectiveness parallel one another, the use of myocardial contrast echocardiography in selected patient cohorts will result in improved diagnostic accuracy and a cost‐effective pattern of care.

Keywords: economics, diagnostic algorithms, cost effectiveness, patient outcomes, disease management, EchoGen®, contrast echocardiography

Full Text

The Full Text of this article is available as a PDF (1.2 MB).

References

  • 1. Kassirer J: Managed care and the morality of the marketplace. N Engl J Med 1995; 333: 50–52 [DOI] [PubMed] [Google Scholar]
  • 2. Marmion M, Deutsch E: Tracers and contrast agents in cardiovascular imaging: Present and future. J Nucl Biol Med 1996; 40: 121–131 [PubMed] [Google Scholar]
  • 3. Patterson RE, Horowitz SF, Eisner RL: Comparison of modalities to diagnose coronary artery disease. Semin Nucl Med 1994; XXIV: 286–310 [DOI] [PubMed] [Google Scholar]
  • 4. Feigenbaum H: Evolution of echocardiography. Circulation 1996; 93: 1321–1327 [DOI] [PubMed] [Google Scholar]
  • 5. Reichek N: Two‐dimensional echocardiography for determination of left ventricular mass. Am J Cardiol Imag 1994; 8: 305–309 [PubMed] [Google Scholar]
  • 6. Correas JM, Quay SC: EchoGenTM emulsion: A new ultrasound contrast agent based on phase shift colloids. Clin Radiol 1996; 51 (suppl 1): 11–14 [PubMed] [Google Scholar]
  • 7. Coulden R, Lipton MJ: Noninvasive imaging for the diagnosis and management of myocardial ischemia. Adv Cardiol Surg 1993; 4: 173–205 [PubMed] [Google Scholar]
  • 8. Stollfuss JC, Kosa I, Ziegler S, Schwanger M: Quantitative assessment of myocardial perfusion: Is it of clinical significance? Q J Nucl Med 1996; 40: 76–84 [PubMed] [Google Scholar]
  • 9. Feigenbaum H: Echocardiography and coronary artery disease. Int J Cardiol Imag 1993; 9 (suppl 2): 55–67 [DOI] [PubMed] [Google Scholar]
  • 10. Chaitman BR: The changing role of the exercise electrocardiogram as a diagnostic and prognostic test for chronic ischemic heart disease. J Am Coll Cardiol 1986; 8: 1195–1210 [DOI] [PubMed] [Google Scholar]
  • 11. Shaw LJ, Peterson ED, Kesler K, Hasselblad V, Califf RM: A metaanalysis of predischarge risk stratification after acute myocardial infarction with stress electrocardiographic, myocardial perfusion, and ventricular function imaging. Am J Cardiol 1996; 78: 1327–1337 [DOI] [PubMed] [Google Scholar]
  • 12. Hachamovitch R, Berman DS, Kiat H. Cohen I, Cabico JA, Friedman J, Diamond GA: Exercise myocardial perfusion SPECT in patients without known coronary artery disease. Circulation 1996; 93: 905–914 [DOI] [PubMed] [Google Scholar]
  • 13. Marwick TH: Recent advances in stress echocardiography. Curr Opin Cardiol 1995; 10: 619–625 [DOI] [PubMed] [Google Scholar]
  • 14. Berman DS, Hachamovitch R, Kiat H, Cohen I, Cabico JA, Wang FP, Friedman JD, Germano G, Van Train K, Diamond GA: Incremental value of prognostic testing in patients with known or suspected ischemic heart disease: A basis for optimal utilization of exercise technetium‐99m sestamibi myocardial perfusion single‐photon emission computed tomography. J Am Coll Cardiol 1995; 26: 639–647 [DOI] [PubMed] [Google Scholar]
  • 15. Armstrong W, Marwick T, Pellika R, Ryan T, Segar D, Lewandowki T, Rubin D, Das M, Lim C, Maxted W: Albunex improves agreement between experienced and less‐experienced echocardiographers for the evaluation of left ventricular wall motion during bicycle stress echocardiography. J Am Soc Echocardiogr 1997; 10: 393 [Google Scholar]
  • 16. Patterson RE, Eisner RL, Horowitz SF: Coronary artery disease/ myocardial infarction: Comparison of cost effectiveness and utility of exercise ECG, single photon emission computed tomography, positron emission tomography, and coronary angiography for diagnosis of coronary artery disease. Circulation 1995; 91: 54–65 [DOI] [PubMed] [Google Scholar]
  • 17. Califf RM, Harrell FE Jr, Lee KL, Rankin JS, Hlatky MA, Mark DB, Jones RH, Muhlbaier LH, Oldham HN Jr, Pryor DB: The evolution of medical and surgical therapy for coronary artery disease. A 15‐year perspective. J Am Med Assoc 1989; 261 (14): 2077–2086 [PubMed] [Google Scholar]
  • 18. American College of Cardiology Database . ACC Homepage (www.acc.org); 1996.
  • 19. Shaw LJ, Kesler K, Eisenstein EL, Heller GV, Travin MI, Duca MD, Taillefer R, Miller DD, for the Economics of Noninvasive Diagnosis (END) Multicenter Study Group : A multicenter study of 11,372 patients to examine cost‐effective strategies for diagnosis of coronary artery disease. J Am Coll Cardiol 1996; 27: 286A [Google Scholar]
  • 20. Hachamovitch R, Berman DS, Shaw LJ, Kiat H, Cohen I, Cabico JA, Friedman J, Diamond GA: The prediction of myocardial infarction versus cardiac death by myocardial perfusion SPECT: Strategic and therapeutic implications. Circulation 1997. (in press)
  • 21. Marwick TH, Nemec JJ, Pashkow J, Stewart WJ, Salcedo EE: Accuracy and limitations of exercise echocardiography in a routine clinical setting. J Am Coll Cardiol 1992; 19: 74–81 [DOI] [PubMed] [Google Scholar]
  • 22. Picano E, Lattanzi F: Dipyridamole echocardiography: A new diagnostic window on coronary artery disease. Circulation 1991; 83: III, 19–26 [PubMed] [Google Scholar]
  • 23. Kaul S: Myocardial contrast echocardiography in coronary artery disease: Potential applications using venous injections of contrast. Am J Cardiol 1995; 75: 61D–68D [DOI] [PubMed] [Google Scholar]
  • 24. Angermann CE, Krüger TM, Junge R, Drewello R, Stempfle HU, Spes CH, Theisen K: Intravenous albunex during transesophageal echocardiography: Quantitative assessment by videodensitometry and integrated backscatter analysis from unprocessed radiofrequency signals. J Am Soc Echocardiogr 1995; 8: 839–853 [DOI] [PubMed] [Google Scholar]
  • 25. Crouse LJ, Cheirif J, Hanly DE, Kisslo JA, Labovitz AJ, Raichlen JS, Schutz RW, Shah PM, Smith MD: Opacification and border delineation improvement in patients with suboptimal endocardial border definition in routine echocardiography: Results of the phase III albunex multicenter trial. J Am Coll Cardiol 1993; 22: 1494–1500 [DOI] [PubMed] [Google Scholar]
  • 26. Tokgözoglu SL, Caner B, Kabakci G, Kes S: Measurement of right ventricular ejection fraction by contrast echocardiography. Int J Cardiol 1997; 59: 71–74 [DOI] [PubMed] [Google Scholar]
  • 27. Villanueva FS, Kaul S: Assessment of myocardial perfusion in coronary artery disease using myocardial contrast echocardiography. Coron Artery Dis 1995; 6: 18–28 [DOI] [PubMed] [Google Scholar]
  • 28. Hu BS, Saltiel F, Popp RL: Effectiveness of limited training in echocardiography for cardiovascular diagnosis (abstr). Circulation 1996; 94: I–253 [Google Scholar]
  • 29. AHA Heart Facts. Chicago, Ill.: American Hospital Publishing Inc., publication; 1995. [Google Scholar]
  • 30. Heupler S, Mehta R, Lobo A, Leung D, Marwick TH: Prognostic implications of exercise echocardiography in women with known or suspected coronary artery disease. J Am Coll Cardiol 1997; 30: 414–420 [DOI] [PubMed] [Google Scholar]
  • 31. Kelsey A, Shaw LJ, Lim SC, Ryan T: Fifteen years of exercise echocardiography: A meta‐analysis. Circulation 1997. (in press)
  • 32. Vasan RS, Larson MG, Benjamin EJ, Evans JC, Levy D: Left ventricular dilatation and the risk of congestive heart failure in people without myocardial infarction. N Engl J Med 1997; 336: 1350–1355 [DOI] [PubMed] [Google Scholar]
  • 33. St. John Sutton M, Pfeffer MA, Plappert T, Rouleau J‐L. Moyé LA, Dagenais GR, Lamas GA, Klein M, Sussex B, Goldman S, Menapace FJ Jr, Parker JO, Lewis S, Sestier F, Gordon DF, McEwan P. Bernstein V, Braunwald E: Quantitative two‐dimensional echocar‐diographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protection effects of captopril. Circulation 1994; 89: 68–75 [DOI] [PubMed] [Google Scholar]
  • 34. Rubin DM, Haluska B. Morehead A, Marwick TH: Improving bicycle stress echo image quality with Albunex. J Am Coll Cardiol 1997; 29: 260A [Google Scholar]
  • 35. Villarraga HR, Foley DA, Mulvagh SL: Contrast echocardiography 1996: A review. Tex Heart Inst J 1996; 23: 90–97 [PMC free article] [PubMed] [Google Scholar]
  • 36. Cohen J, Bruns E, Hausner E, Gottdiener J. Dick C, Picard M, Crouse L, for the FS069 Multi‐Center Study Group : Multicenter trial comparing FS069 and albunex for left ventricular endocardial border delineation. J Am Coll Cardiol 1997; 29: 519A 9060887 [Google Scholar]
  • 37. Kangarloo H, Ho BK, Lufkin RB, Barbaric Z. Kirlew K, Yaghmai S, Scholem D, Steckel RJ: Effect of conversion from a fee‐for‐service plan to a capitation reimbursement system on a circumscribed outpatient radiology practice of 20,000 persons. Radiology 1996; 201 (1):79–84 [DOI] [PubMed] [Google Scholar]
  • 38. Grayburn PA: How good is echocardiography at assessing myocaridal viability? Am J Cardiol 1995; 76: 1183–1184 [DOI] [PubMed] [Google Scholar]
  • 39. Bonow RO: Identification of viable myocardium. Circulation 1996; 94: 2674–2680 [DOI] [PubMed] [Google Scholar]
  • 40. Cheirif J, Meza M, Murgo JP: Dobutamine echocardiography and myocardial contrast echocardiography: Two new techniques for the assessment of myocardial viability. Tex Heart Inst J 1995; 22: 33–39 [PMC free article] [PubMed] [Google Scholar]
  • 41. Nanto S, Lim Y‐J, Masuyama T, Hori M, Nagata S: Diagnostic performance of myocardial contrast echocardiography for detection of stunned myocardium. J Am Soc Echocardiogr 1995; 9: 314–319 [DOI] [PubMed] [Google Scholar]
  • 42. Nallamouthu N, Araujo L, Russell J, Heo J, Iskandrian AD: Prognostic value of simultaneous perfusion and function assessment using technetium‐99m sestamibi. Am J Cardiol 1996; 78: 562–564 [DOI] [PubMed] [Google Scholar]
  • 43. Shaw LJ, Heinle SK, Borges‐Neto S, Kesler K. Coleman E, Jones RH, for the Duke Noninvasive Research Working Group : Prognosis in patients with coronary amage quality with Albunex. J Am Coll Cardiol 1997; 29: 260A [Google Scholar]
  • 44. Fetters J, Peterson ED, Shaw LJ, Newby LK, Califf RM: Sex‐specific differences in coronary artery disease risk factors, evaluation. and treatment: Have they been adequately evaluated? Am Heart J 1996; 131: 796–813 [DOI] [PubMed] [Google Scholar]
  • 45. Peterson ED, Shaw LJ, Oddone E: An empirical approach to evaluation of chest pain in women. J Clin Outcomes Manag 1995; 2: 9–23 [Google Scholar]
  • 46. Shaw LJ, Miller DD, Romeis JC, Kargl D, Younis LT. Chaitman BR: Gender differences in the noninvasive evaluation and management of patients with suspected coronary artery disease. Ann Intern Med 1994; 120: 559–566 [DOI] [PubMed] [Google Scholar]
  • 47. Mark DB, Shaw L, Delong ER, Califf RM, Pryor DB: Absence of sex bias in the referral of patients for cardiac catheterization. N Engl J Med 1994; 330: 1101–1106 [DOI] [PubMed] [Google Scholar]
  • 48. Hlatky MA, Pryor DB, Harrell FE Jr, Califf RM, Mark DB. Rosati RA: Factors affecting sensitivity and specificity of exercise echocardiography: Multivariable analysis. Am J Med 1984; 77: 64–71 [DOI] [PubMed] [Google Scholar]
  • 49. Barolsky SM, Gilbert CA, Faruqui A, Nutter DO, Schlant RC: Differences in electrocardiographic responses to exercise of women and men: A non‐Baycsian factor. Circulation 1979; 60: 1021–1027 [DOI] [PubMed] [Google Scholar]
  • 50. Johnson LL: Sex‐specific issues relating to nuclear cardiology. J Nucl Cardiol 1995; 2: 339–348 [DOI] [PubMed] [Google Scholar]
  • 51. Shaw LJ, Kesler K, Peterson ED, Delong ER, Borges‐Neto S, Califf RM, for the Duke Noninvasive Research Working Group : Long‐term prognostic implications of abnormal stress electrocardiographic or myocardial perfusion scintigraphic measures in patients with angiographically‐insignificant coronary artery disease. J Am Coll Cardiol 1996; 27: 78A [Google Scholar]
  • 52. Peterson ED, Shaw LJ, Califf RM: Risk stratification after myocardial infarction. Ann Intern Med 1997; 126: 561–582 [DOI] [PubMed] [Google Scholar]
  • 53. Wackers FJT, Heller GV, Sotwers S, Hendel RC, Herman S, Baron J, Daher E, for the Acute Chest Pain Tetrofosmin Trial : Normal rest tetrofosmin SPECT imaging in patients with chest pain and normal or nondiagnostic ECG in the emergency department is associated with lower need for subsequent cardiac catheterization and revascularization. J Am Coll Cardiol 1997; 29: 196A [Google Scholar]
  • 54. Bilodeau L, Théroux P, Gregoire J, Gagnon D, Arsenault A: Technetium‐99m sestamibi tomography in patients with spontaneous chest pain: Correlations with clinical, electrocardiographic and angiographic findings. J Am Coll Cardiol 1991; 18: 1684–1691 [DOI] [PubMed] [Google Scholar]
  • 55. Braunwald E, Mark DB, Jones RH, Archibald N, McCauley KM, Smith EE III, Green LA, Cheitlin MD, Swain JA, Morrison DA, Edwards C, Brown L, Goldman L, Fuster V, Cowan M, Grines CL, Rose GC, Topol EJ, Concannon CA, Lytle BW, Willerson JT, Mushlin AI: Clinical practice guideline number 10: Evaluation instruments for the care of patients with unstable angina. U.S. DHHS. PHS. Washington, DC. AHCPR Publication No. 95–0602
  • 56. Newby LK, Califf RM, Guerci A, Weaver WD, Col J, Horgan JH, Mark DB, Stebbins A, Van de Werf F, Gore JM, Topol EJ: Early discharge in the thrombolytic era: An analysis of criteria for uncomplicated infarction from the Global Utilization of Streptokinase and t‐PA for Occluded Coronary Arteries (GUSTO) trial. J Am Coll Cardiol 1996; 27: 625–632 [DOI] [PubMed] [Google Scholar]
  • 57. Fleischmann KF, Goldman L, Robiolio PA, Lee RT, Johnson PA, Cook EF, Lee TH: Echocardiographic correlates of survival in patients with chest pain. J Am Coll Cardiol 1994; 23: 1390–1396 [DOI] [PubMed] [Google Scholar]
  • 58. Villanueva FS, Camarano G, Ismail S, Goodman NC, Sklenar J, Kaul S: Coronary reserve abnormalities in the infarcted myocardium: Assessment of myocardial viability immediately versus late after reflow by contrast echocardiography. Circulation 1996; 94: 748–754 [DOI] [PubMed] [Google Scholar]
  • 59. Christian TF, Clements IP, Gibbons RJ: Noninvasive identification of myocardium at risk with acute myocardial infarction and nondiagnostic electrocardiograms with technetium‐99m‐sestamibi. Circulation 1994; 89: 1615–1620 [DOI] [PubMed] [Google Scholar]
  • 60. Eagle KA, Brundage BH, Chaitman BR, Ewy GA, Fleisher LA, Hertzer NR, Leppo JA, Ryan T, Schlant RC, Spencer WH III, Spittell JA Jr, Twiss RD, Ritchie JL, Cheitlin MD, Gardner TJ, Garson A Jr, Lewis RP, Gibbons RJ, O'Rourke RA, Ryan TJ: Guidelines for perioperative cardiovascular evaluation for noncardiac surgery. Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Committee on Perioperative Cardiovascular Evaluation for Noncardiac Surgery. Circulation 1996; 93: 1278–1317 [PubMed] [Google Scholar]
  • 61. Shaw LJ, Eagle KA, Gersh BJ, Miller DD: Meta‐analysis of intravenous dipyridamole thallium‐201 imaging (1985–1994) and dobutamine echocardiography (1990–1994) for risk stratification prior to vascular surgery. J Am Coll Cardiol 1996; 27: 787–798 [DOI] [PubMed] [Google Scholar]
  • 62. Shaw LJ, Hachamovitch R, Eisenstein E, Berman D, Cohen M, Udelson J, Miller DD: Cost implications for implementing a selective preoperative risk screening approach for peripheral vascular surgery patients. Am J Managed Care (in press) [PubMed]
  • 63. Wellman G, Sherrin T: Applying principles of pharmacoeconomic evaluation to perflenapent emulsion, a new echocardiographic contrast agent used in cardiac function testing. Clin Ther 1997; 19: 837–846 (in press) [DOI] [PubMed] [Google Scholar]
  • 64. Laupacis A, Feeny D, Detsky AS, Tugwell PX: How attractive does a new technology have to be to warrant adoption and utilization?: Tentative guidelines for using clinical and economic evaluations. Can Med Assoc J 1992; 146: 473–481 [PMC free article] [PubMed] [Google Scholar]
  • 65. Goldman L, Garber AM, Grover SA, Hlatky MA: Task Force 6. Cost effectiveness of assessment and management of risk factors. J Am Coll Cardiol 1996; 27: 1020–1030 [DOI] [PubMed] [Google Scholar]
  • 66. Shaw LJ, Dittrich HC, Crouse LJ, Dent J, for the FS069 Multi‐Center Study Group : Use of intravenous Optison contrast echocardiography reduces downstream resource use and enhances cost savings. Presented at the 11th Annual Symposium on Advances in Echocardiography, 1996.
  • 67. Hsiah A, Jollis JG, Kesler KL, DeLong ER, Collins M, Donovan CL, Waugh RA, Ryan T, Kisslo J: Prognostic value of transthoracic echo in the Duke Cardiovascular Disease Database. Circulation 1996; 94: 1–27 8964107 [Google Scholar]
  • 68. Shaw LJ, Dittrich HC: Use of intravenous Optison contrast echocardiography reduces downstream resource use and enhances cost savings. Acad Radiol 1997. (in press) [DOI] [PubMed]

Articles from Clinical Cardiology are provided here courtesy of Wiley

RESOURCES